chr1-161921766-A-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_007348.4(ATF6):​c.1804+9386A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.93 in 152,300 control chromosomes in the GnomAD database, including 66,011 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.93 ( 66011 hom., cov: 32)

Consequence

ATF6
NM_007348.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.28

Publications

6 publications found
Variant links:
Genes affected
ATF6 (HGNC:791): (activating transcription factor 6) This gene encodes a transcription factor that activates target genes for the unfolded protein response (UPR) during endoplasmic reticulum (ER) stress. Although it is a transcription factor, this protein is unusual in that it is synthesized as a transmembrane protein that is embedded in the ER. It functions as an ER stress sensor/transducer, and following ER stress-induced proteolysis, it functions as a nuclear transcription factor via a cis-acting ER stress response element (ERSE) that is present in the promoters of genes encoding ER chaperones. This protein has been identified as a survival factor for quiescent but not proliferative squamous carcinoma cells. There have been conflicting reports about the association of polymorphisms in this gene with diabetes in different populations, but another polymorphism has been associated with increased plasma cholesterol levels. This gene is also thought to be a potential therapeutic target for cystic fibrosis. [provided by RefSeq, Aug 2011]
ATF6 Gene-Disease associations (from GenCC):
  • achromatopsia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
  • ATF6-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • achromatopsia
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.976 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATF6NM_007348.4 linkc.1804+9386A>C intron_variant Intron 15 of 15 ENST00000367942.4 NP_031374.2 P18850A8K383
ATF6NM_001437597.1 linkc.1861+9386A>C intron_variant Intron 15 of 15 NP_001424526.1
ATF6NM_001410890.1 linkc.1801+9386A>C intron_variant Intron 15 of 15 NP_001397819.1
ATF6XM_011509309.1 linkc.1858+9386A>C intron_variant Intron 15 of 15 XP_011507611.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATF6ENST00000367942.4 linkc.1804+9386A>C intron_variant Intron 15 of 15 1 NM_007348.4 ENSP00000356919.3 P18850

Frequencies

GnomAD3 genomes
AF:
0.930
AC:
141545
AN:
152182
Hom.:
65950
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.968
Gnomad AMI
AF:
0.714
Gnomad AMR
AF:
0.927
Gnomad ASJ
AF:
0.950
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.924
Gnomad FIN
AF:
0.919
Gnomad MID
AF:
0.953
Gnomad NFE
AF:
0.906
Gnomad OTH
AF:
0.944
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.930
AC:
141665
AN:
152300
Hom.:
66011
Cov.:
32
AF XY:
0.931
AC XY:
69325
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.968
AC:
40239
AN:
41576
American (AMR)
AF:
0.927
AC:
14186
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.950
AC:
3298
AN:
3472
East Asian (EAS)
AF:
0.999
AC:
5183
AN:
5190
South Asian (SAS)
AF:
0.924
AC:
4458
AN:
4824
European-Finnish (FIN)
AF:
0.919
AC:
9740
AN:
10604
Middle Eastern (MID)
AF:
0.952
AC:
280
AN:
294
European-Non Finnish (NFE)
AF:
0.906
AC:
61637
AN:
68016
Other (OTH)
AF:
0.944
AC:
1996
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
508
1015
1523
2030
2538
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
910
1820
2730
3640
4550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.916
Hom.:
10745
Bravo
AF:
0.933
Asia WGS
AF:
0.967
AC:
3361
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.67
DANN
Benign
0.68
PhyloP100
-2.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6687226; hg19: chr1-161891556; API